![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Project Name: NanoWarriors TechXplore 2007-2008, sponsored by the National Science & Technology Education Partnership (NSTEP).
This TechXplore project was completed by Bergen County Academies, Hackensack, NJ, with technical support from Jim Lowery of ITM- Instruments Technology, Machinery. Cystic fibrosis is an escalating phenomenon with detrimental effects. A major part of this life shortening disease is the presence of excess mucus in the lungs. Currently, there is no cure and the only option for victims is periodically coughing up the build up of mucus. We propose packaging a chemical (possibly a gene since cystic fibrosis is a genetic disease) into an inhalable nanoparticle, which will eventually release the chemical into the lungs, reducing the mucus synthesis.
Problem The cystic fibrosis gene is located on chromosome seven and in cystic fibrosis patients; a DNA mutation in this gene involves the production of a protein called (Cystic Fibrosis Transmembrane conductance Regulator), a part of the cell membrane in certain special epithelial (surface) cells that generate mucus. These special cells might line the airways of the nose and lungs or the stomach wall. One missing amino acid in the proteins calls for the majority of cystic fibrosis cases. The gene region has 230,000 DNA base pairs that spell out a series of 1,480 amino acids that curl up to make the CFTR protein. The little triangle in the diagram below shows the location of the three-base-pair deletion mutation.
A normal gene makes CFTR that regulates the passage of chloride ions and hence the secretion of mucus in epithelial (surface) cells lining lungs. This is the corrected gene that we posses in our hands today. However, the major hindrance that has been experienced so far in administering this gene is an immune system rejection because of the chemical properties of the nanoparticles used to deliver the gene. Our team’s approach was to find a finite tactic to overcome such a hindrance. Solution
Mentor Comments: IDEAS 10/26/07 SilverAssist
As our mentor mentioned, the world is most definitely going nanoscale. This was the reason that the team eventually decided to reevaluate the solution of a micromachine or a box-like prototype that that has the capability to suck up mucus. Even micro- may be too large for the lungs to handle and the liklihood of an immune system rejection to occur is very high. Therefore, nano was the road to set about on. Upon starting our investigation on a nanoparticle that can be surgically inserted in the body, all team members automatically arrived to the conclusion that a surgery may eventually prove to be costly for patients. The chemical that the nanoparticle is supposed to disperse will eventually run out and repeated surgery involving the lungs may be fatal. Though we already had the corrected cystic fibrosis gene, its route of administration is still baffling many researchers. One in-school nanotechnology expert suggested that the team ponder over Exubera, which was the recent first FDA approved inhaled version of insulin. (http/::www.diabetesnet.com/diabetes_treatments/insulin_inhaled.php) One alternative sight that it has fared well in the competition is into the lungs. Therefore, instead of the gene having to be surgically inserted, a simply inhalation with such a mechanism can safely deliver the gene into the lungs. However, there is a great likelihood that the gene by itself will trigger an immune system rejection as well. Therefore, designing the architecture of an outer layer or coating around the gene became absolutely vital. Upon much research, the team agreed upon the many properties of silver itself. Within the past year or so, silver has gained popularity as a safe, effective antimicrobial agent, and scientists are already looking into using nanochrystalline silver as a likely potential in the treatment for cystic fibrosis patients. Additionally, silver in the form of nanoparticles are sufficiently small to pass through the outer cell membranes of lung cells and enter the cells’ inner mechanisms. Coating the gene with a recognized antibiotic was an intial idea at first, but increasing doses lead to resistance and grave sideffects. Therefore, experimenting even with a minimal dose of antibiotic coating was out of question. Silver, on the other hand, runs a much less likelihood of resistance while providing minimal risks for side effects. Scientist at Leicester University have already built a machine that can produce such silver nanoparticles, which can be suspended in a liquid. In other words, it can be put into an Exubera-like aerosol and breathed into the lungs. What happens once the silver nanoparticles are produced? Well, these nanoparticles have already been used to create SilvaGard, a FDA approved silver nanoparticle antimicrobial coating. While AcryMed is using this silver nanotechnology breakthrough as protection against the formation of infection-causing biofilms or bacteria, our team has decided to employ this silver nanoparticle coating around the corrected cystic fibrosis gene. Upon its administration into the lungs via an inhaler, the silver nanoparticles have the ability to create tenacious bonds to any material, as tested, making it trouble-free to bond with the membranes of lung cells. (http://www.acrymed.com/medical.html) Since the silver nanoparticles create a large surface area, their antimicrobial properties would tackle the cystic fibrosis infections within the surface of the lungs while the gene will be delivered to the cells. According to a study conducted at Oregon Health and Sciences University, such silver nanotechnology implements low toxicity levels because the nanoparticles were eventually removed through the feces, solid excretory product evacuated from the bowels. Moreover, the international nanotechnology business directory, Nanovip.com, labels such silver nanotechnology as well established, effective, and cost effective.
Team Profile Bergen County Technical Schools, Hackensack, NJ The team members were able to improve teamwork and researching skills. They also learned about the field of nanotechnology and its application to everyday life. The team cultured an understanding about the cooperative parts of biology and technology, and how they can help lives. The team learned a lot and had fun! -------------------------- Team Roles: Jessica K.: My strength is my ability to communicate between members of the group and the outside mentor. The role best suited for me is to compile and edit the information gathered by all of the members and relay the mentor’s messages. Krizia A.: My strength is my ability to organize and design. The task best suited for me is leading the design process and coordinating the website. Linda Z.: My strength is the ability to research in depth information on the topic and communicate with the inside mentor. The task best suited for me is gathering, verifying, and compiling the necessary information for the topic. Bhumi P.: My strength is my ability to come up with new ideas and alternatives, as well as researching necessary information. The role best suited for me is compiling information and relaying it to the inside mentor. I am also responsible for the written report. Mentors: Jim Lowry was our assigned mentor who emailed us regularly with advice. Dr. Robert Pergolizzi and Mrs. Donna Leonardi were our in-school mentor who provided us with information that helped us develop our idea. Mrs. Rios was our project facilitator. Thanks: Our team would like to extend our sincere gratitude to Jim Lowry for his mentorship. Without his support and guidance, we would not have been able to develope our idea as fully as we have. We would also like to thank Mrs. Rios for encouraging us and never giving up on our idea. We would like to thank Dr. Robert Pergolizzi and Mrs. Donna Leonardi for their time and support. Thank you TechXplore for this very educational opportunity and learning experience! Feedback
Analysis: Despite the fact that many have heard of the advantages of nanotechnology and the inhaling of nanoparticles, it is apparent from the survey results that not may have heard of employing silver nanoparticles as a method of gene delivery since it is a novel and effective research phenomena that has just hit the market. The population that we surveyed knew at least once victim of cystic fibrosis but could not think of an alternative solution in helping such people since there are no methods that have been clearly listed as the ultimate treatment. Therefore, seventy-eight percent of our survey population found the incorporation of nanotechnology and gene therapy as essential for such victims. Since nanotechnology and gene therapy are the forefronts in their respective fields and have fared well, many agreed that such a concept was realistic for future production. The majority of our survey population understood the potentials of such an advance for cystic fibrosis patients and stated that they would definitely participate in a clinical trial if they were diagnosed with cystic fibrosis themselves. Though fifty-six percent of our survey population considered that a patient him or herself will not be able to personally finance such a procedure, seventy-two percent agreed that insurance companies will most definitely endorse it. Interactions with Mentor: Describe your job, and how would it contribute to solving our problem? My job involves designing mechanical machines and devices. The other aspect of my job is to oversee our design team to create commonality in our different projects. I use a Computer Aided Design Software (SolidWorks) which enables me to build the entire machine and perform some testing right on the computer. I create the drawings used by our machine shop to manufacture the parts and buy motors and pneumatic cylinders. The entire machine is assembled by our assembly team with my guidance. Our programming department creates the control program and brings the machine to life. Most of our machines are computer controlled with some type of robot inside. One or our devices is called the Perfusion Apparatus. This device is built into a Nikon Microscope for the purpose of injecting different medicines directly into cells for medical research. If you visit our website at www.itm-texas.com you will see what type of machines we build.
I Graduated from High School and took 2 years of college courses in the engineering field, however, due to family pressures, I was unable to graduate. This has not stopped me from learning. I look for every opportunity to take in seminars and classes related to my field and have become a successful machine designer. Remember, If it was easy, everyone would be doing it. Technologies Associated With Our Solution: Biotechnology NanoTechnology Chemical Engineering Link to resource www.associatedcontent.com/article/ 63339/career_profile_nanotechnology.html Presentation These photos are from our class presentation of our project. |